Influence of Patient Sex on Pain Control and Multimodal Analgesia in Total Knee Arthroplasty
Knee Osteoarthritis, Pain, Postoperative
About this trial
This is an interventional treatment trial for Knee Osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female, age 18-80
- Undergoing primary unilateral TKA for primary osteoarthritis
- English speaking
- Patients whose primary residence is in a home and not a facility or rehabilitation center.
Exclusion Criteria:
- Chronic (>6 months) use of neuromodulators pregabalin or gabapentin.
- Pregnancy or lactation
- Prior history of adverse reactions to pregabalin
- Coexisting chronic pain condition rated ≥50mm on 100-mm VAS requiring narcotics.
- Coexisting condition leading to sedation or dizziness
- Kidney disease
- History of angioedema
- History of depression with suicidal ideation.
- Extensive history of opioid/ substance use and/or abuse.
- Receiving active or maintenance treatment for cancer or solid organ and/or marrow transplant.
- Patient staying less than one night in the hospital.
- Patients with a history of chronic obstructive pulmonary disease (COPD) with supplementary oxygen requirements.
Sites / Locations
- Northwell Health Orthopedic Institute at Great Neck
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Multimodal analgesia regimen including pregabalin
Multimodal analgesia regimen not including pregabalin
For the pregabalin group, patient will be provided with an oral preoperative pregabalin dose of 150mg on the day of surgery. Patient will continue pregabalin 75mg two times a day, for two weeks postoperatively. For both the intervention and control groups, the operative technique and additional perioperative analgesic modalities will follow a standard protocol
For the non-pregabalin group, patient will be undergo total knee arthroplasty with the same operative technique and additional perioperative analgesic modalities will follow a standard protocol